Ubs Group Ag Omega Therapeutics, Inc. Transaction History

Ubs Group Ag

$452 Billion
Q3 2024

A detailed history of Ubs Group Ag transactions in Omega Therapeutics, Inc. stock. As of the latest transaction made, Ubs Group Ag holds 2,992 shares of OMGA stock, worth $2,363. This represents 0.0% of its overall portfolio holdings.

Number of Shares

2,992

Previous 1,447 106.77%

Holding current value

$2,363

Previous $2,000 50.0%

% of portfolio

0.0%

Previous 0.0%

13 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	BUY	$1.22 - $2.25 $1,884 - $3,476	1,545 Added 106.77%	2,992 $3,000
Q2 2024 Aug 13, 2024	SELL	$1.86 - $3.2 $48,849 - $84,041	-26,263 Reduced 94.78%	1,447 $2,000
Q1 2024 May 13, 2024	BUY	$2.73 - $5.32 $270 - $526	99 Added 0.36%	27,710 $101,000
Q4 2023 Feb 09, 2024	BUY	$1.35 - $3.21 $19,561 - $46,512	14,490 Added 110.43%	27,611 $83,000
Q3 2023 Nov 09, 2023	SELL	$2.15 - $5.68 $4,125 - $10,899	-1,919 Reduced 12.76%	13,121 $28,000
Q2 2023 Aug 11, 2023	BUY	$5.6 - $9.66 $61,521 - $106,124	10,986 Added 270.99%	15,040 $84,000
Q1 2023 May 12, 2023	BUY	$4.81 - $10.95 $11,592 - $26,389	2,410 Added 146.59%	4,054 $24,000
Q4 2022 Feb 08, 2023	SELL	$4.22 - $7.05 $8,271 - $13,818	-1,960 Reduced 54.38%	1,644 $9,000
Q3 2022 Nov 10, 2022	BUY	$3.63 - $6.65 $13,082 - $23,966	3,604 New	3,604 $20,000
Q2 2022 Aug 10, 2022	SELL	$2.01 - $7.19 $596 - $2,135	-297 Closed	0 $0
Q1 2022 May 16, 2022	SELL	$6.24 - $14.04 $9,079 - $20,428	-1,455 Reduced 83.05%	297 $2,000
Q4 2021 Feb 14, 2022	BUY	$11.33 - $29.38 $8,701 - $22,563	768 Added 78.05%	1,752 $20,000
Q3 2021 Nov 15, 2021	BUY	$16.0 - $22.51 $15,744 - $22,149	984 New	984 $19,000

Others Institutions Holding OMGA

# of Institutions

Shares Held

43.4M

Call Options Held

25.8K

Put Options Held

View Full List

About Omega Therapeutics, Inc.

Ticker OMGA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 47,853,400
Market Cap $37.8M
Description
Omega Therapeutics, Inc. operates as a development-stage biopharmaceutical company. Its OMEGA Epigenomic Programming platform is designed to coopt nature's operating system by harnessing the power of epigenetics, the mechanism for gene control and cell differentiation. The company is developing omega epigenomic controller (OEC) candidates to up-...

More about OMGA

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Ubs Group Ag, based on Form 13F filings with the SEC.

News

Stay updated on Ubs Group Ag with notifications on news.

Account